1、F-1 1 ny20012777x5_f1.htm F-1TABLE OF CONTENTSAs filed with the Securities and Exchange Commission on January 25,2024Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM F-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933APRINOIA Therapeutics Inc.(Exact na

2、me of Registrant as specified in its charter)Not Applicable(Translation of Registrants name into English)Cayman Islands 2834 Not Applicable(State or Other Jurisdiction ofIncorporation or Organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)245 Main

3、 Street,2nd FloorCambridge,MA 02142Telephone:617-225-4415(Address,including zip code,and telephone number,including area code,of Registrants principal executive offices)245 Main Street,2nd FloorCambridge,MA 02142Telephone:617-225-4415(Name,address,including zip code,and telephone number,including ar

4、ea code,of agent for service)Copies to:Will H.Cai,Esq.Timothy Pitrelli,Esq.Cooley LLPc/o 35th FloorTwo Exchange Square8 Connaught PlaceCentral,Hong Kong+852 3758-1200 Reid S.Hooper,Esq.Cooley LLP1299 Pennsylvania AvenueNW,Suite 700Washington,DC 20004(202)842 7899 Michael J.BlankenshipWinston&Strawn

5、LLP800 Capitol Street,Suite 2400Houston,Texas 77002(713)651 2600Approximate date of commencement of proposed sale to the public:as soon as practicable after the effective date of this registrationstatement.If any of the securities being registered on this Form are to be offered on a delayed or conti

6、nuous basis pursuant to Rule 415 under theSecurities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check thefollowing box and list the Securities Act registration statement number of